Literature DB >> 17701360

Involvement of both tumor necrosis factor-alpha-induced necrosis and p53-mediated caspase-dependent apoptosis in nephrotoxicity of cisplatin.

Takahisa Yano1, Yoshinori Itoh, Misaki Matsuo, Takehiro Kawashiri, Nobuaki Egashira, Ryozo Oishi.   

Abstract

We previously reported that necrosis occurs predominantly in porcine renal tubular LLC-PK1 cells, when the cells were exposed transiently to a high concentration of cisplatin. Moreover, we demonstrated that generation of reactive oxygen species and subsequent production of tumor necrosis factor-alpha (TNF-alpha) through phosphorylation of p38 MAPK are implicated in the pathogenesis of cisplatin-induced renal cell injury. However, some TUNEL-positive cells appeared in renal proximal tubules of rats after systemic injection of cisplatin, suggesting an involvement of apoptosis. In the present study, we found in LLC-PK1 cells that both apoptosis and necrosis were elicited when the cells were exposed to 200 microM cisplatin for 1 h followed by incubation for 24 h in the presence of 20 microM cisplatin. The cisplatin-induced necrosis was largely attenuated by the antioxidant N-acetylcysteine, while apoptosis was prevented by the specific inhibitors for caspases-2, -8, and -3 and a p53 inhibitor pifithrin-alpha but not by the p38 MAPK inhibitor SB203580. On the other hand, SB203580 attenuated the cisplatin-induced increase in TNF-alpha production. These findings suggest that p53-mediated activations of caspases-2, -8 and -3 play a key role in cisplatin-induced renal cell apoptosis, while oxidative stress-induced TNF-alpha synthesis via p38 MAPK phosphorylation contributed to the necrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701360     DOI: 10.1007/s10495-007-0110-8

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  8 in total

Review 1.  Pathologies associated with the p53 response.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-07       Impact factor: 10.005

2.  Alterations of phosphoproteins in NCI-H526 small cell lung cancer cells involved in cytotoxicity of cisplatin and titanocene Y.

Authors:  Ulrike Olszewski; Anthony Deally; Matthias Tacke; Gerhard Hamilton
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

3.  TIM2 gene deletion results in susceptibility to cisplatin-induced kidney toxicity.

Authors:  Aparna Krishnamoorthy; Matthew E Clement; Eileen O'Leary; Joseph V Bonventre; Vishal S Vaidya
Journal:  Toxicol Sci       Date:  2010-08-11       Impact factor: 4.849

4.  Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity.

Authors:  Zhixia Song; Jiefu Zhu; Qingqing Wei; Guie Dong; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09

5.  OTOTOXIC EFFECTS OF CARBOPLATIN IN ORGANOTYPIC CULTURES IN CHINCHILLAS AND RATS.

Authors:  Ding Dalian; Jiang Haiyan; Fu Yong; Richard Salvi; Shinichi Someya; Masaru Tanokura
Journal:  J Otol       Date:  2012-12

6.  ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma.

Authors:  Jian-Jun Xie; Yang-Min Xie; Bo Chen; Feng Pan; Jin-Cheng Guo; Qing Zhao; Jin-Hui Shen; Zhi-Yong Wu; Jian-Yi Wu; Li-Yan Xu; En-Min Li
Journal:  Oncotarget       Date:  2014-09-30

7.  Beneficial effects of fermented black ginseng and its ginsenoside 20(S)-Rg3 against cisplatin-induced nephrotoxicity in LLC-PK1 cells.

Authors:  Myoung-Sik Han; Im-Ho Han; Dahae Lee; Jun Min An; Su-Nam Kim; Myoung-Sook Shin; Noriko Yamabe; Gwi Seo Hwang; Hye Hyun Yoo; Suk-Jung Choi; Ki Sung Kang; Hyuk-Jai Jang
Journal:  J Ginseng Res       Date:  2015-07-09       Impact factor: 6.060

8.  Sustained oxidative stress causes late acute renal failure via duplex regulation on p38 MAPK and Akt phosphorylation in severely burned rats.

Authors:  Yafei Feng; Yi Liu; Lin Wang; Xiaoqing Cai; Dexin Wang; Kaimin Wu; Hongli Chen; Jia Li; Wei Lei
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.